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Abstract
Background: Acute cauda equina syndrome is an uncommon but significant neurologic presentation due to a
variety of underlying diseases. Anatomical compression of nerve roots, usually by a lumbar disk hernia is a common
cause in the general population, while inflammatory, neoplastic, and ischemic causes have also been recognized.
Among human immunodeficiency virus (HIV) infected patients with acquired immunodeficiency syndrome,
infectious causes are encountered more frequently, the most prevalent of which are: cytomegalovirus, herpes
simplex virus 1/2, varicella zoster virus, and Mycobacterium tuberculosis infections. Studies of cauda equina syndrome
in well-controlled HIV infection are lacking. We describe such a case of cauda equina syndrome in a well-controlled
HIV-infected patient, along with a brief review of the literature regarding the syndrome’s diagnosis and treatment in
individuals with HIV infection.
Case presentation: A 36-year-old Greek male, HIV-positive patient presented with perineal and left hemiscrotal
numbness, lumbar pain, left-sided sciatica, and urinary incontinence. Magnetic resonance imaging of the patient’s
lumbar spine revealed intrathecal migration of a fragment from an intervertebral lumbar disk exerting pressure on
the cauda equina. A cerebrospinal fluid examination, brain computed tomography scan, spine magnetic resonance
imaging, and serological test results were negative for central nervous system infections. Our patient underwent
emergency neurosurgical spinal decompression, which resolved most symptoms, except for mild urinary
incontinence.
Conclusions: Noninfectious etiologies may also cause cauda equina syndrome in HIV-infected individuals, especially
in well-controlled disease under antiretroviral therapy. Prompt recognition and treatment of the underlying cause is
important to minimize residual symptoms. Targeted antimicrobial chemotherapy is used to treat infectious causes,
while prompt surgical decompression is favored for anatomical causes of cauda equina syndrome in the
HIV-infected patient.
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Background
Cauda equina syndrome (CES) is a polyradiculopathy
resulting from nerve compression or inflammation of
the lower spinal cord, which commonly presents with
motor and sensory abnormalities of the lower limbs,
along with bladder and sphincter dysfunction. Numerous
causes of CES have been reported to date, including
spinal disk herniation, trauma, spinal stenosis, iatrogenic
causes, neoplasms, ischemia, inflammation, and infec-
tions [1]; an etiology for a portion of cases cannot be
identified. In patients with advanced human immuno-
deficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS), central nervous system (CNS) infections,
usually due to cytomegalovirus (CMV) or Mycobacter-
ium tuberculosis (MTB), comprise the most common
causes of CES [2–5]. However, noninfectious processes
may also lead to CES in individuals infected with HIV,
especially when the disease is well controlled, as in the
case report that follows. Prompt diagnosis of the syn-
drome, identification of the underlying cause, and appro-
priate treatment are crucial, since progression is rapid
and prognosis can sometimes be unfavorable if specific
treatment is delayed, especially in the context of HIV
infection.
Case presentation
A 36-year-old Greek male, HIV-positive patient was ad-
mitted to the Neurology Department due to perineal
and left hemiscrotal numbness, lumbar pain, left-sided
sciatica, and urinary incontinence; his symptoms began
5 days prior to admission, and were not accompanied by
fever. The patient’s occupational history was significant
for frequent weight-lifting during his daily duties as an
orderly. He had been on a triple antiretroviral regimen
with didanosine (ddI), d4T (stavudine), and efavirenz for
the past 6 years, while diagnosis of HIV was made 12
years earlier. Recent testing reported a CD4+ cell count
of 1036 cells/mL and an undetectable HIV viral load
(<50 copies/mL); the Center for Diseases Control (CDC)
stage of his disease was C3.
The neurological examination revealed decreased
strength of the left gastrocnemius and absence of the left
ankle jerk reflex, while his plantar reflexes were indiffer-
ent bilaterally. The remaining physical examination was
noncontributory.
Given that the patient’s neurological signs and symp-
toms were indicative of CES, a magnetic resonance im-
aging (MRI) scan of his lumbar spine was initially
performed. Imaging revealed left dorsolateral interverte-
bral disc herniation of L3-L4, prominent dorsomedian
intervertebral disc herniation of L5-S1, and a small frag-
ment within the vertebral canal (at S1) that was exerting
pressure on cauda equina fibers. The latter finding was
compatible with a fragment originating from the L5-S1
intervertebral disk. A brain computed tomography (CT)
scan, cerebrospinal fluid (CSF) examination, and sero-
logical test results for CNS infections, including CMV
and herpes simplex virus 1/2 (HSV-1/2) were negative.
Further testing for infectious causes would have been
pursued in the absence of an obvious anatomical cause
of the observed syndrome.
Because of the acute onset of CES in our patient,
emergency neurosurgical spinal decompression was
deemed necessary. The procedure was successful overall,
leading to resolution of most neurological symptoms,
with the exception of a persistent, mild urinary incontin-
ence. Specifically, early postoperative neurological find-
ings were largely limited to the left lower limb and
perineum, and included: slightly decreased lower limb
muscle strength (L5-S1 myotomes), mild sensory impair-
ment on the lateral surface of his foot (L5 dermatome),
and mild paresthesia of his buttocks, left hemiscrotum,
and dorsolateral thigh. Two-point discrimination was
1.5–2 cm, with a mild decrease on his left side. Vibration
sensation in the affected regions was normal, and his
plantar reflexes were flexor bilaterally.
Neurological follow-up performed 1 week later re-
vealed physiological muscle strength, no sensory deficits,
and partial recovery of his bladder dysfunction. Uro-
logical symptoms have been previously described in the
literature as presenting a delayed recovery following de-
compression surgery [6]. Although intervertebral lumbar
disc herniation with posterior migration of a sequestered
disk fragment has been previously reported as a rare
cause of CES in immunocompetent patients [7], this is
the first case report in an HIV-positive patient.
Discussion
Differential diagnosis
Despite the relative rarity of CES among HIV-positive
patients, prompt diagnosis and treatment of the syn-
drome is crucial due to the potential of persistent debili-
tating symptoms [8] (such as permanent loss of bowel/
bladder control and paralysis of the legs). It is, thus, ne-
cessary to perform an immediate and thorough clinical,
imaging, and laboratory investigation in every HIV-
positive patient whose symptoms are suggestive of the
syndrome in order to identify its cause. An MRI scan of
the lumbar spine should be performed within the first
few hours of symptom onset [9]. This aims to quickly
identify many of the causes of the syndrome (Table 1),
such as simple protrusion of the intervertebral disc,
compression of the cauda equina, or focal inflammation
(for example, caused by infection) [8].
In the general population, CES usually results from
compression of spinal nerve roots due to intervertebral
disk hernias, vertebral canal stenosis, or spinal neo-
plasms [1]. Intervertebral lumbar disc herniation with
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posterior migration of a disc fragment has been reported
as a rare cause of the syndrome in otherwise healthy
persons [7, 10, 11]. As for noncompressive causes, ische-
mia and spinal arachnoiditis have been described [1].
These processes could be the cause of CES in HIV-
infected individuals, especially in the setting of well-
controlled infection under antiretroviral therapy.
The differential diagnosis of CES in immunocomprom-
ised patients with HIV infection includes several more,
mostly infectious, causes (Table 1). In HIV-infected
individuals with advanced HIV/AIDS, the syndrome may
present as an acute polyradiculopathy [12, 13]. When this
occurs, it is often caused by CNS infection that
affects the cauda equina or conus medullaris. CMV
and MTB are the most common infectious causes
among HIV-positive patients [5, 13, 14], which can be
in the context of concurrent infection of the retina
and other organs [2, 13].
In order to rule out CMV CNS infection, a lumbar
puncture may be performed for CSF analysis, along with
serological and molecular testing. CSF laboratory
findings suggestive of CMV CNS infection include high
cell count with unaltered polymorphonuclear cells
(usually >60 %), decreased glucose (<50 % of serum
measurement), and significantly increased protein levels,
whereas neoplastic cells are absent [2, 13]. Nevertheless,
reports of normal CSF findings in CMV infections have
also been published [13]. Thus, polymerase chain reac-
tion (PCR) of the CSF for CMV DNA is also required
before CMV infection is excluded in HIV-positive
patients (92 % sensitivity and 94 % specificity) [15],
whereas branched chain DNA (bDNA) assay for CMV
DNA and immunoperoxidase staining for CMV antigen
can also be considered [16, 17]; CSF viral cultures are
less useful for initial diagnosis, as they lack sensitivity
[13, 15]. In addition to molecular testing, MRI with
intravenous gadolinium contrast may be necessary to
detect neural CMV lesions [18].
Myeloradiculitis is usually a complication of tubercu-
lous meningitis or HSV-2 CNS infection that can also
lead to CES (even in successfully treated patients) [4, 19]
and yields negative CSF examination results [20, 21].
Depending on patient history and locally endemic
diseases, ruling out HSV-1/2, varicella zoster virus
(VZV), and Mycobacterium tuberculosis (MTB) should
also be considered; molecular testing may also be neces-
sary in these cases, as other testing can be nondiagnostic
[4, 19]; other, more rare causes should be considered on
an individualized basis.
Also, impaired immune response in HIV-positive pa-
tients with syphilis can cause an atypical, aggressive form
of neurosyphilis, which can manifest as painful polyradi-
culopathy [22]; rapidly progressive, asymmetrical sensori-
motor abnormalities of the lower limbs, bladder and
sphincter are the hallmark of this form of neurosyphilis.
In the full-blown syndrome, the patient may present with
sensory loss of the lower body’s dorsal surface, bilateral
sciatic nerve pain, paresthesia, decreased strength of the
lower limbs or chronic flaccid paraplegia, absence of deep
tendon reflexes, and bladder/sphincter dysfunction [1].
Lymphomas have also been reported to cause CES in
HIV-positive patients [5, 23]. Finally, primary CES in these
patients is a benign, idiopathic form of the syndrome that
has a slow clinical progression, mild neurologic deficits,
and a generally better prognosis, which may explain those
cases where no anatomical causes, infectious agents or
neoplastic cells can be identified [24]. CSF examination
results in the primary syndrome reveal moderate mono-
nuclear pleocytosis and mildly increased protein levels.
A systematic meta-analysis of more than 200 individual
cases of CES found that the majority (84 %) of patients
experience a progressive development of symptoms,
beginning with sensory-motor findings in the lower ex-
tremities (early CES) [25]. Bowel and sphincter symptoms
tend to develop later on, in what the authors of the study
describe as “incomplete CES” and “CES in retention” [25].
Table 1 Causes of cauda equina syndrome in human immunodeficiency virus positive patients
Anatomical compression Spinal infection (especially
in advanced HIV/AIDS)
Other causes
Abscess [32, 33] Cryptococcus [34] Connective tissue disease [24, 35]
Spinal hematoma (for example, from trauma) [36] Cytomegalovirus [37] Iatrogenic adhesive arachnoiditis [38]
Intervertebral disk hernia [28] Epstein-Barr virus [39] HIV (idiopathic cauda equina syndrome) [14]
Intrathecal disk fragment [7] Herpes simplex virus (mainly HSV-2) [19] Spinal ischemia [40]
Pathologic spinal fracture (for example, due to
osteoporosis or neoplasia) [41]
Treponema pallidum [22]
Spinal neoplasia (especially lymphoma) [42–44] Schistosoma [45]
Vertebral canal stenosis [46] Toxoplasma [47]
Mycobacterium tuberculosis [20]
Varicella zoster virus [48, 49]
HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome
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Thus, suspecting CES when bilateral lower limb and/or
perineal sensorimotor findings are present could lead to
more rapid diagnosis and subsequent management in
both well-controlled and advanced HIV infection.
Treatment
Treatment should always be specific, unless the cause of
the syndrome cannot be identified. In the case of the
latter, short-term alleviation of symptoms and long-term
complete neurological recovery of the patient are
sought.
In the case of lumbar disk herniation causing CES in
HIV-positive patients, surgery is considered more effect-
ive than medical management in the short term [26]. In
the single relevant study, no significant difference in the
response of HIV-infected individuals to surgical treat-
ment of lumbar disk herniation was found, as compared
to uninfected patients [27]. It is estimated that 1–3 % of
all patients with intervertebral lumbar disc herniation
may manifest with CES [28, 29]. These cases of the
syndrome, as well as those caused by other anatomical
compressive phenomena, undergo surgical decompres-
sion that is performed within the first 24 hours of symp-
tom presentation, in order to achieve maximum
postoperative neurological recovery [29, 30]. Delayed
surgical decompression (more than 48 hours after symp-
tom onset versus treatment within 24–48 hours) has
been correlated with a much higher rate of postoperative
bladder and anal sphincter dysfunction, serious motor
deficits, sexual dysfunction, and persistent pain [29].
In HIV-positive patients, when CES is due to CMV
CNS infection, treatment may consist of intravenous ad-
ministration of ganciclovir for 2–3 weeks; foscarnet can
also be added to the treatment regimen when there is an
increased risk for treatment failure, as in patients who
have previously received ganciclovir, or in those with
persistent polymorphonuclear pleocytosis, decreased
glucose, and/or detection of CMV in serial CSF tests
[3, 31]. In ganciclovir-resistant cases, foscarnet infusion
can be performed alone or in combination with cido-
fovir. Progression of neurological symptoms is usually
controlled within 2 weeks of treatment, while serious
defects may persist even after treatment completion
[2, 12]. Contrarily, in idiopathic CES spontaneous reso-
lution of the syndrome is most often the case [12].
Initiation of empirical treatment may be considered in
advanced HIV/AIDS patients with CES until the etiology
is revealed, in order to prevent irreversible progression
of neurological deficits [4]. Given the high occurrence
of Herpesviridae and MTB infections leading to CES
among HIV-infected patients, it may be reasonable to
consider ganciclovir, acyclovir, and antimycobacterials in
empirical regimens, while patient history and findings
will further guide the empirical treatment selection [4].
Conclusions
It is important for acutely presenting CES to be sus-
pected in patients with bilateral lower limb and/or peri-
neal sensorimotor deficits, so as to mitigate permanent
neurological damage. In working up HIV-positive pa-
tients, it can be important to exclude infectious causes
of the syndrome, but differential diagnosis should also
include etiologies leading to CES in the general popula-
tion, especially in patients with well-controlled HIV
infection.
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